Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

4 claims · each scored for market impact

What matters in this story

1
Analysts expect Amgen to report a year-over-year earnings decline of 7.81% per share in its upcoming earnings disclosure. — Expected declines in earnings per share typically exert downward pressure on a stock's price ahead of reports.
-0.40
2
Amgen's revenue is projected to increase by 2.87% year-over-year to $9.44 billion in the upcoming quarter. — Modest revenue growth provides a partial offset to declining earnings, suggesting some top-line resilience.
+0.20
3
Amgen is trading at a Forward P/E ratio of 15.48, which is a discount compared to its industry average of 21.35. — Trading at a discount to peers can make a stock more attractive to value investors, providing a potential price floor.
+0.20
4